The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Melatonin for Insomnia in Children With Autism Spectrum Disorders
Abstract
We describe our experience in using melatonin to treat insomnia, a common sleep concern, in children with autism spectrum disorders. One hundred seven children (2—18 years of age) with a confirmed diagnosis of autism spectrum disorders who received melatonin were identified by reviewing the electronic medical records of a single pediatrician. All parents were counseled on sleep hygiene techniques. Clinical response to melatonin, based on parental report, was categorized as (1) sleep no longer a concern, (2) improved sleep but continued parental concerns, (3) sleep continues to be a major concern, and (4) worsened sleep. The melatonin dose varied from 0.75 to 6 mg. After initiation of melatonin, parents of 27 children (25%) no longer reported sleep concerns at follow-up visits. Parents of 64 children (60%) reported improved sleep, although continued to have concerns regarding sleep. Parents of 14 children (13%) continued to report sleep problems as a major concern, with only 1 child having worse sleep after starting melatonin (1%), and 1 child having undetermined response (1%). Only 3 children had mild side-effects after starting melatonin, which included morning sleepiness and increased enuresis. There was no reported increase in seizures after starting melatonin in children with pre-existing epilepsy and no new-onset seizures. The majority of children were taking psychotropic medications. Melatonin appears to be a safe and well-tolerated treatment for insomnia in children with autism spectrum disorders. Controlled trials to determine efficacy appear warranted.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Characterizing Sleep in Children with Autism Spectrum Disorders: A Multidimensional Approach
Malow, B. A., Marzec, M. L., McGrew, S. G., Wang, L., Henderson, L. M., & Stone, W. L. (2006) · Sleep · doi:10.1093/sleep/29.12.1563 · Cited by 485 · cited 1×
“Risperidone (48), aripiprazole (23), olanzapine (22), quetiapine (13), ziprasidone (7), clomipramine (3), haloperidol (1), benztropine (1), and lithium (1).”
BackgroundSelf-citationNocturnal excretion of 6-sulphatoxymelatonin in children and adolescents with autistic disorder
Tordjman, S., Anderson, G. M., Pichard, N., Charbuy, H., & Touitou, Y. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2004.11.003 · Cited by 296
Cited by
Sleep Behaviors and Sleep Quality in Children with Autism Spectrum Disorders
Souders, M. C., Mason, T. B. A., Valladares, O., Bucan, M., Levy, S. E., Mandell, D. S., Weaver, T. E., & Pinto-Martin, J. (2009) · Sleep · doi:10.1093/sleep/32.12.1566 · Cited by 436
Sleep in children with autistic spectrum disorder
Cortesi, F., Giannotti, F., Ivanenko, A., & Johnson, K. (2010) · Sleep Medicine · doi:10.1016/j.sleep.2010.01.010 · Cited by 355
Sleep in Children with Autism Spectrum Disorder
Souders, M. C., Zavodny, S., Eriksen, W., Sinko, R., Connell, J., Kerns, C., Schaaf, R., & Pinto-Martin, J. (2017) · Current Psychiatry Reports · doi:10.1007/s11920-017-0782-x · Cited by 307
Current role of melatonin in pediatric neurology: Clinical recommendations
Bruni, O., Alonso-Alconada, D., Besag, F., Biran, V., Braam, W., Cortese, S., Moavero, R., Parisi, P., Smits, M., Van der Heijden, K., et al. (2015) · European Journal of Paediatric Neurology · doi:10.1016/j.ejpn.2014.12.007 · Cited by 280
Malow, B. A., Byars, K., Johnson, K., Weiss, S., Bernal, P., Goldman, S. E., Panzer, R., Coury, D. L., & Glaze, D. G. (2012) · Pediatrics · doi:10.1542/peds.2012-0900i · Cited by 275
Self-citation
Metadata
- Authors
- Andersen, I. M., Kaczmarska, J., McGrew, S. G., & Malow, B. A.
- Venue
- Journal of Child Neurology
- Publisher
- SAGE Publications
- Published
- 2008-01-29
- Volume
- 23
- Issue
- 5
- Pages
- 482-485
- ISSN
- 0883-0738 (ISSN-L)
- 1708-8283
- OpenAlex
- W2105514611
- Cited by
- 228
- References
- 2
- FWCI
- 28.23
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.